News

Assessing dystrophies and other muscle diseases at the nanometer scale by atomic force microscopy.

van Zwieten RW, Puttini S, Lekka M, Witz G, Gicquel-Zouida E, Richard I, Lobrinus JA, Chevalley F, Brune H, Dietler G, Kulik A, Kuntzer T, Mermod N. Nanomedicine...

12 giugno 2014


Chloride channels in myotonia congenita assessed by velocity recovery cycles.

Tan SV, Z'Graggen WJ, Boërio D, Rayan DR, Norwood F, Ruddy D, Howard R, Hanna MG, Bostock H. Muscle Nerve. 2014 Jun;49(6):845-57.

11 giugno 2014


Transcriptional network analysis in muscle reveals AP-1 as a partner of PGC-1α in the regulation of the hypoxic gene program.

Baresic M, Salatino S, Kupr B, van Nimwegen E, Handschin C. Mol Cell Biol. 2014 Jun 9.

09 giugno 2014


Characterization of the RNA recognition mode of hnRNP G extends its role in SMN2 splicing regulation.

Moursy A, Allain FH, Cléry A. Nucleic Acids Res. 2014 Apr 1.

07 aprile 2014


Morphological and functional remodelling of the neuromuscular junction by skeletal muscle PGC-1α.

Arnold AS, Gill J, Christe M, Ruiz R, McGuirk S, St-Pierre J, Tabares L, Handschin C. Nat Commun. 2014 Apr 1;5:3569.

02 aprile 2014


Modulation of PGC-1α activity as a treatment for metabolic and muscle-related diseases.

Svensson K, Handschin C. Drug Discov Today. 2014 Mar 12. Review

19 marzo 2014


Molecular targets to treat muscular dystrophies.

Kinter J, Sinnreich M. Swiss Med Wkly. 2014 Feb 19.

24 febbraio 2014